We're proud to get to tell Atomic AI's story. @ElliotHershberg & I teamed up on this one to explain the science, the business, the potential impact, and why we invested.
RESEARCH
-

Atomic AI Develops RNA Therapeutic Portfolio for Pharma Licensing
By
–
Atomic AI plans to develop its own internal portfolio of hundreds of druggable RNA structures and therapeutic designs in the next few years. Each structure represents the potential for billions in revenue via licensing agreements with pharma companies. As an example:
-
AI Breakthrough: Targeting Previously Undruggable Cancer Proteins
By
–
More importantly, the company might contribute to cures for previously incurable diseases. "Undruggable cancer drug targets like MYC and KRAS—which are overexpressed in 75% of cancers—can be revisited and potentially blocked before the protein is ever even produced."
-

AlphaFold: DeepMind’s Breakthrough in Protein Structure Prediction
By
–
You've probably heard of AlphaFold, DeepMind's model that cracked the 50-year-old protein structure prediction problem.
-

Atomic AI Breakthrough in RNA Structure Prediction
By
–
Atomic AI cracked the RNA structure prediction problem. The company sits right at the intersection of two revolutions: 1. The RNA Revolution (mRNA vaccines)
2. The AlphaFold Revolution (AI to predict structure) -

Atomic AI Raises $35M Series A for Structural Biology
By
–
Atomic AI fits Not Boring Capital's thesis perfectly. Hard Startup: science ft. on the cover of Science
Value: clear path to billions in revenue
So What?: potential to save millions of lives
Bits & Atoms: AI x Structural Bio Here's the story of Atomic AI & its $35M Series A: -

AtomicAICo Unlocks RNA-Targeting Potential With AI
By
–
Meet @AtomicAICo
. Based on @raphaeljlt
's research, which was featured on the cover of Science in 2021, @AtomicAICo is unlocking the potential of RNA-targeting and RNA-based medicine. It's a beautiful mix of AI and structural biology, bits and atoms. -
Who uses big open-source LLMs in production? Tasks and advantages over Curie
By
–
Who uses big, open-source LLMs like BLOOM, OPT, or GPT-NeoX in production? What tasks are they good at? What are the advantages over Curie?
-

Randi Zuckerberg Discusses Generative AI and ChatGPT Future
By
–
I had an interesting chat recently with @randizuckerberg about generative AI, chatGPT, and where AI is heading. If you have SiriusXM, here's how you can find it…
-
ML Workshop on Probabilistic Weather Climate Science Methods
By
–
Submit and join Call for Contributions: Workshop on Probabilistic Approaches in Weather and Climate Science (8-9 May, Kigali). So many interesting questions for ML Methods to contribute to. Happening just after #ICLR2023 and details at https://
climate-workshop23.github.io